Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal
Journal of Comparative Effectiveness Research · 2024
DOI: 10.57264/cer-2024-0102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Hilde Ten Berge und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diagnostic Accuracy, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Lung Neoplasms, Cost-Benefit Analysis, Tomography, X-Ray Computed, Early Detection of Cancer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Lung cancer is the most common cause of cancer death in Portugal. The Dutch–Belgian lung cancer screening (LCS) study (NELSON), the biggest European LCS study, showed a lung cancer mortality reduction in a high-risk population when being screened. In this study, the cost–effectiveness of LCS, based on the NELSON study protocol and outcomes, was evaluated compared with no screening in Portugal.
Methods
The present study modified an established decision tree by incorporating a state-transition Markov model to evaluate the health-related advantages and economic implications of low-dose computed tomography (LDCT) LCS from the healthcare standpoint in Portugal. The analysis compared screening versus no screening for a high-risk population aged 50–75 with a smoking history. Various metrics, including clinical outcomes, costs, quality-adjusted life years (QALYs), life-years (LYs) and the incremental cost–effectiveness ratio (ICER), were calculated to measure the impact of LDCT LCS. Furthermore, scenario and sensitivity analyses were executed to assess the robustness of the obtained results.
Results
Annual LCS with volume-based LDCT resulted in €558 million additional costs and 86,678 additional QALYs resulting in an ICER of €6440 per QALY for one screening group and a lifetime horizon. In total, 13,217 premature lung cancer deaths could be averted, leading to 1.41 additional QALYs gained per individual diagnosed with lung cancer. Results are robust based on the sensitivity analyses.
Conclusion
This study showed that annual LDCT LCS for a high-risk population could be cost-effective in Portugal based on a willingness to pay a threshold of one-time the GDP (€19,290 per QALY gained).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Diagnostic Accuracy, Groningen, The Netherlands.
- Unit of Global Health, Faculty of Medical Sciences, University of Groningen, Groningen, The Netherlands.
- IPO Porto, Comprehensive Cancer Center (Porto.CCC), RISE@CI-IPOP (Health Research Network), Porto, Portugal.
- Thoracic Surgery, Hospital da Luz, Lisboa, Portugal.
- Pulmonology Department, Centre Hospitalier du Nord, Luxembourg.
- ICBAS School of Medicine & Biomedical Sciences, University of Porto (UP), Porto, Portugal.
Zitieren
APA
Berge, H. T., Togka, K., Pan, X., Borges, M., Martelo, F. P., Guedes, F., Cabral, D., Teixeira, E., Fernandes, G., Ferreira, L., Figueiredo, S., Sousa, R., Barradas, L., Estevinho, F., Araújo, A., Hespanhol, V., & Medeiros, R. (2024). Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0102
Vancouver
Berge HT, Togka K, Pan X, Borges M, Martelo FP, Guedes F, et al. Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2024-0102
BibTeX
@article{Berge2024,
author = {Berge, Hilde Ten and Togka, Katerina and Pan, Xuanqi and Borges, Marina and Martelo, Fernando Palma and Guedes, Fernando and Cabral, Daniel and Teixeira, Encarnação and Fernandes, Gabriela and Ferreira, Lurdes and Figueiredo, Sara and Sousa, Rita and Barradas, Lourdes and Estevinho, Fernanda and Araújo, António and Hespanhol, Venceslau and Medeiros, Rui},
title = {Cost–effectiveness of lung cancer screening with volume computed tomography in Portugal},
journal = {Journal of Comparative Effectiveness Research},
year = {2024},
doi = {10.57264/cer-2024-0102}
}
EUVIMED